CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PharmGenHUB aims to enhance personalized medicine in the Western Balkans by developing pharmacogenomics capabilities at the Institute of Molecular Genetics and Genetic Engineering in Serbia. Through collaboration with European partners, the project focuses on identifying drug-gene interactions and creating digital tool…
Personalized medicine uses pharmacogenomics (PGX) to individualize therapy upon patients’ unique DNA profiles.
With ~200,000 deaths/year in Europe due to adverse drug reactions, it has become an imperative to improve treatment.
In Western Balkans (WB), individualization of therapy is done sporadically. IMGGE (Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia) is a pioneer in the PGX in WB.
PharmGenHUB will strengthen IMGGE’s PGX R&I potential by exchanging k…
INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Rio Patras
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Slovenia, Ljubljana
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Trieste
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
